Sue J Goldie Selected Research

Sue J Goldie Research Topics

Disease

22	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2012 - 10/2003
12	Neoplasms (Cancer) 04/2016 - 05/2002
7	HIV Infections (HIV Infection) 05/2008 - 04/2002
4	Infections 06/2011 - 10/2003
4	Papillomavirus Infections 08/2008 - 10/2003
4	Disease Progression 09/2006 - 08/2002
2	Adenocarcinoma 04/2016 - 01/2013
2	Maternal Death 09/2012 - 04/2010
2	Opportunistic Infections (Opportunistic Infection) 09/2010 - 08/2002
2	Condylomata Acuminata (Genital Wart) 10/2009 - 08/2008
2	Uterine Cervical Dysplasia 01/2007 - 01/2006
2	Atypical Squamous Cells of the Cervix 01/2006 - 05/2002
2	Acquired Immunodeficiency Syndrome (AIDS) 08/2005 - 12/2002
2	Fibrosis (Cirrhosis) 07/2003 - 12/2002
1	Vaccine-Preventable Diseases 09/2017
1	Atrophy 04/2016
1	Body Weight (Weight, Body) 02/2016
1	Yellow Fever 04/2013
1	Japanese Encephalitis 04/2013
1	Rubella (German Measles) 04/2013
1	Measles 04/2013
1	Multiple Endocrine Neoplasia Type 2b (MEN 3) 01/2013
1	Pneumonia (Pneumonitis) 09/2010
1	Rotavirus Infections 01/2009
1	Gastroenteritis 01/2009
1	Stomach Neoplasms (Stomach Cancer) 01/2009
1	Recurrent respiratory papillomatosis 08/2008
1	Hepatitis B 01/2008
1	Human Influenza (Influenza) 01/2008
1	Chickenpox 01/2008
1	Hepatitis A (Hepatitis, Infectious) 01/2008
1	Endometrial Neoplasms (Endometrial Cancer) 02/2007
1	Squamous Intraepithelial Lesions 01/2006
1	Tachycardia (Tachyarrhythmias) 01/2006
1	Carcinogenesis 06/2005
1	Carcinoma (Carcinomatosis) 01/2004
1	Persistent Infection 10/2003
1	Asthma (Bronchial Asthma) 05/2003
1	Hepatitis 12/2002
1	Coronary Disease (Coronary Heart Disease) 11/2002
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 04/2002

Drug/Important Bio-Agent (IBA)

15	DNA (Deoxyribonucleic Acid)IBA 12/2012 - 05/2002
14	VaccinesIBA 09/2017 - 10/2003
4	RNA (Ribonucleic Acid)IBA 09/2006 - 08/2002
3	Papillomavirus Vaccines (HPV Vaccines)IBA 04/2013 - 08/2006
3	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 09/2006 - 04/2002
2	N(alpha)-carbamoylglutamine-1-amide (NCGA)IBA 04/2016 - 01/2013
2	CholesterolIBA 02/2016 - 11/2002
1	Pepsinogen A (Pepsinogen)IBA 04/2016
1	Biomarkers (Surrogate Marker)IBA 04/2016
1	Blood Glucose (Blood Sugar)IBA 02/2016
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 02/2016
1	Triglycerides (Triacylglycerol)IBA 02/2016
1	Hepatitis B AntigensIBA 04/2013
1	Guanosine Diphosphate (GDP)IBA 01/2009
1	Combined VaccinesIBA 08/2008
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 01/2008
1	NucleosidesIBA 05/2007
1	Protease Inhibitors (Protease Inhibitor)IBA 05/2007
1	Reverse Transcriptase InhibitorsIBA 05/2007
1	Anti-Arrhythmia AgentsIBA 01/2006
1	Acetic Acid (Vinegar)FDA LinkGeneric 11/2005
1	Aligeron (AS 2)IBA 06/2005
1	AIDS VaccinesIBA 09/2004
1	Alanine Transaminase (SGPT)IBA 07/2003
1	Ribavirin (Virazole)FDA LinkGeneric 12/2002
1	Interferon-alpha (Interferon Alfa)IBA 12/2002
1	InterferonsIBA 12/2002

Therapy/Procedure

8	Therapeutics 04/2010 - 08/2002
4	Highly Active Antiretroviral Therapy (HAART) 09/2010 - 04/2002
2	Postnatal Care 09/2012 - 04/2010
2	Secondary Prevention 08/2006 - 11/2002
1	Contraception (Birth Control) 04/2010
1	Adjuvant Radiotherapy 02/2007
1	Conservative Treatment 01/2006
1	Liver Transplantation 05/2003
1	Art Therapy 09/2002